Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

This study has been completed.
Information provided by:
MedImmune LLC Identifier:
First received: September 12, 2003
Last updated: November 26, 2007
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2006
  Estimated Primary Completion Date: No date given